Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009 Jul 23; 361(4):358-67.
View in:
PubMed
subject areas
Adolescent
Adult
Angiogenesis Inhibitors
Antibodies, Monoclonal
Female
Hearing Loss
Humans
Male
Middle Aged
Neurofibromatosis 2
Neuroma, Acoustic
Neuropilin-1
Neuropilin-2
Retrospective Studies
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-2
Young Adult
authors with profiles
Scott Randall Plotkin, M.D.,Ph.D.
Rakesh K. Jain, Ph.D.
Frederick George Barker II, M.D.
Timothy P. Padera, Ph.D.
Anat Stemmer-Rachamimov, M.D.